Atlantic Grupa (ATGR) Q2 2026 earnings summary

Executive summary

• Achieved strong revenue and profitability growth in H1 2026, with sales up 10.6% year-over-year to EUR 618.8 million and double-digit increases in EBITDA and net profit, despite challenging market conditions and elevated raw material prices.

• Growth was broad-based across all strategic business and distribution units, with standout performances from Pharmacy Business, Savoury Spreads, Coffee, and International Markets, especially in Germany and Austria.

• Continued strategic investments, portfolio expansion, and innovation, including the launch of Smokice in savoury snacks and new Cedevita beverage formats.

• Recognized for ESG leadership, gender equality, and brand strength, winning multiple awards including Regional ESG Leader Gold and CFO of the Year.

Financial highlights

• Sales reached EUR 618.8 million, up 10.6% year-over-year; turnover at EUR 626.3 million, up 10.3%.

• EBITDA rose 16.7% to EUR 59.1 million; EBIT up 26.6% to EUR 31.6 million; net profit up 35.9% to EUR 20.1 million.

• Normalized EBITDA margin improved by 54 bp to 9.5%; normalized net profit margin up 67 bp to 3.2%.

• Free cash flow increased significantly due to higher operating cash flow and lower capex.

• Dividend of EUR 1.75 per share (EUR 23.25 million total) paid in July 2026.

Outlook and guidance

• Management raised full-year 2026 expectations, targeting sales of approximately EUR 1.3 billion and normalized EBITDA above EUR 115 million, with a continued slight increase in EBITDA margin.

• Over EUR 60 million in capital investments planned for 2026, focused on Coffee and Snacks segments.

• Strategic focus on leadership, portfolio expansion, operational excellence, digital transformation, and sustainability.